Lithuanian Prostate Diagnostics Implementation Guide
0.0.1 - ci-build
Lithuanian Prostate Diagnostics Implementation Guide
0.0.1 - ci-build
Lithuanian Prostate Diagnostics Implementation Guide, published by Lithuanian Medical Library. This guide is not an authorized publication; it is the continuous build for version 0.0.1 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7LT/ig-lt-prostate/ and changes regularly. See the Directory of published versions
<DiagnosticReport xmlns="http://hl7.org/fhir">
<id value="diagnosticReport-prostate-mpmri-report-example"/>
<meta>
<profile
value="https://hl7.lt/fhir/prostate/StructureDefinition/mpmri-report-lt-prostate"/>
</meta>
<language value="en"/>
<text>
<status value="generated"/>
<div xml:lang="en" lang="en"><hr/><p><b>English</b></p><hr/><p class="res-header-id"><b>Generated Narrative: DiagnosticReport diagnosticReport-prostate-mpmri-report-example</b></p><a name="diagnosticReport-prostate-mpmri-report-example"> </a><a name="hcdiagnosticReport-prostate-mpmri-report-example"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Language: en</p><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-mpmri-report-lt-prostate.html">Diagnostic Report: Prostate mpMRI</a></p></div><h2><span title="Codes:{http://hl7.eu/fhir/imaging-r5/CodeSystem/Hl7EuDocumentTypes imaging-report-v0-0-1}, {http://snomed.info/sct 719178004}">Imaging Report V0.0.1</span> (<span title="Codes:{http://loinc.org 18748-4}">Diagnostic imaging study</span>) </h2><table class="grid"><tr><td>Subject</td><td>Tomas Kazlauskas(official) Male, DoB: 1980-01-01 ( http://hospital-lt.lt/patient-id#HOSPLT-20001 (use: usual, ))</td></tr><tr><td>When For</td><td>2024-05-27 10:30:00+0000</td></tr><tr><td>Performer</td><td> <a href="PractitionerRole-practitioner-role-radiologist-example.html">PractitionerRole </a></td></tr></table><p><b>Report Details</b></p><table class="grid"><tr><td><b>Code</b></td><td><b>Value</b></td><td><b>Flags</b></td><td><b>Note</b></td></tr><tr><td><a href="Observation-imfinding-prostate-lesion1-example.html"><span title="Codes:{http://snomed.info/sct 49755003}">Morphologically abnormal structure</span></a></td><td/><td>Final</td><td/></tr><tr><td><a href="Observation-observation-prostate-pirads-lesion1-example.html"><span title="Codes:{http://snomed.info/sct 1345044005}">Assessment using Prostate Imaging-Reporting and Data System (procedure)</span></a> (<span title="Codes:{http://snomed.info/sct 716913001}">Structure of anterior middle regional part of transition zone of right half prostate</span>)</td><td>5</td><td>Final</td><td><blockquote><div><p>Anterior transition zone lesion (~32 mm), extending across midline. Very high suspicion on mpMRI.</p>
</div></blockquote></td></tr><tr><td><a href="Observation-observation-prostate-t2-score-lesion1-example.html"><span title="Codes:{http://dicom.nema.org/resources/ontology/DCM 110805}">T2 Weighted MR Signal Intensity</span></a></td><td>5</td><td>Final</td><td><blockquote><div><p>T2 score 5 in transition zone lesion.</p>
</div></blockquote></td></tr><tr><td><a href="Observation-observation-prostate-dwi-score-lesion1-example.html"><span title="Codes:{http://dicom.nema.org/resources/ontology/DCM 113043}">Diffusion weighted</span></a></td><td>5</td><td>Final</td><td><blockquote><div><p>Marked diffusion restriction (DWI score 5).</p>
</div></blockquote></td></tr><tr><td><a href="Observation-observation-prostate-adc-score-lesion1-example.html"><span title="Codes:{http://dicom.nema.org/resources/ontology/DCM 113041}">Apparent Diffusion Coefficient</span></a></td><td>5</td><td>Final</td><td><blockquote><div><p>Low ADC corresponding to restricted diffusion (ADC score 5).</p>
</div></blockquote></td></tr><tr><td><a href="Observation-observation-prostate-dce-score-lesion1-example.html"><span title="Codes:{http://dicom.nema.org/resources/ontology/DCM 110816}">T1 Weighted Dynamic Contrast Enhanced MR Signal Intensity</span></a></td><td>5</td><td>Final</td><td><blockquote><div><p>Dynamic contrast enhancement reported as positive (+).</p>
</div></blockquote></td></tr><tr><td><a href="Observation-observation-prostate-precise-followup-example.html"><span title="Codes:{https://tx.hl7.lt/fhir/CodeSystem/prostate-precise-component precise-assessment}">PRECISE longitudinal assessment</span></a></td><td><span title="Codes:{https://tx.hl7.lt/fhir/CodeSystem/prostate-precise-category 3}">PRECISE 3 - Stable disease</span></td><td>Final</td><td><blockquote><div><p>Stable disease compared to prior MRI examinations.</p>
</div></blockquote></td></tr></table><div><p>PI-RADS 5 lesion in the anterior transition zone (~32 mm), extending across midline. PRECISE 3 stable disease. No seminal vesicle invasion, no neurovascular bundle involvement, no regional lymphadenopathy. Possible capsular contact anteriorly.</p>
</div></div>
</text>
<status value="final"/>
<category>
<coding>
<system value="http://loinc.org"/>
<code value="18748-4"/>
<display value="Diagnostic imaging study"/>
</coding>
</category>
<code>
<coding>
<system
value="http://hl7.eu/fhir/imaging-r5/CodeSystem/Hl7EuDocumentTypes"/>
<code value="imaging-report-v0-0-1"/>
<display value="Imaging Report V0.0.1"/>
</coding>
<coding>
<system value="http://snomed.info/sct"/>
<code value="719178004"/>
<display
value="Multiparametric magnetic resonance imaging of prostate (procedure)"/>
</coding>
</code>
<subject>🔗
<reference value="Patient/patient-male-example"/>
</subject>
<encounter>🔗
<reference value="Encounter/encounter-prostate-diagnostic-example"/>
</encounter>
<effectiveDateTime value="2024-05-27T10:30:00Z"/>
<performer>🔗
<reference
value="PractitionerRole/practitioner-role-radiologist-example"/>
</performer>
<result>🔗
<reference value="Observation/imfinding-prostate-lesion1-example"/>
</result>
<result>🔗
<reference
value="Observation/observation-prostate-pirads-lesion1-example"/>
</result>
<result>🔗
<reference
value="Observation/observation-prostate-t2-score-lesion1-example"/>
</result>
<result>🔗
<reference
value="Observation/observation-prostate-dwi-score-lesion1-example"/>
</result>
<result>🔗
<reference
value="Observation/observation-prostate-adc-score-lesion1-example"/>
</result>
<result>🔗
<reference
value="Observation/observation-prostate-dce-score-lesion1-example"/>
</result>
<result>🔗
<reference
value="Observation/observation-prostate-precise-followup-example"/>
</result>
<supportingInfo>
<type>
<coding>
<system value="http://terminology.hl7.org/CodeSystem/v2-0936"/>
<code value="RSLT"/>
</coding>
</type>
<reference>🔗
<reference value="Observation/observation-prostate-psa-example"/>
</reference>
</supportingInfo>
<supportingInfo>
<type>
<coding>
<system value="http://terminology.hl7.org/CodeSystem/v2-0936"/>
<code value="RSLT"/>
</coding>
</type>
<reference>🔗
<reference value="Observation/observation-prostate-volume-example"/>
</reference>
</supportingInfo>
<supportingInfo>
<type>
<coding>
<system value="http://terminology.hl7.org/CodeSystem/v2-0936"/>
<code value="SCI"/>
</coding>
</type>
<reference>🔗
<reference value="Observation/observation-prostate-psad-example"/>
</reference>
</supportingInfo>
<supportingInfo>
<type>
<coding>
<system value="http://terminology.hl7.org/CodeSystem/v2-0936"/>
<code value="RSLT"/>
</coding>
</type>
<reference>🔗
<reference
value="Observation/observation-prostate-gleason-gradegroup-example"/>
</reference>
</supportingInfo>
<composition>🔗
<reference value="Composition/composition-prostate-mpmri-report-example"/>
</composition>
<conclusion
value="PI-RADS 5 lesion in the anterior transition zone (~32 mm), extending across midline. PRECISE 3 stable disease. No seminal vesicle invasion, no neurovascular bundle involvement, no regional lymphadenopathy. Possible capsular contact anteriorly."/>
</DiagnosticReport>